Improve Patient Outcomes Comfort + Convenience = Compliance · ADVANCED PNEUMATIC COMPRESSION...

8
FLEXITOUCH PLUS | PRODUCT OVERVIEW Improve Patient Outcomes Comfort + Convenience = Compliance FLEXITOUCH ® PLUS ADVANCED PNEUMATIC COMPRESSION SYSTEM

Transcript of Improve Patient Outcomes Comfort + Convenience = Compliance · ADVANCED PNEUMATIC COMPRESSION...

Page 1: Improve Patient Outcomes Comfort + Convenience = Compliance · ADVANCED PNEUMATIC COMPRESSION SYSTEM. ... (JAMA) Dermatology Ñ Study Highlights A study of 718 lymphedema patients

FLEX

ITO

UC

H P

LUS

|

PR

OD

UC

T O

VER

VIE

W

Improve Patient Outcomes Comfort + Convenience = Compliance

FLEXITOUCH® PLUSADVANCED PNEUMATIC COMPRESSION SYSTEM

Page 2: Improve Patient Outcomes Comfort + Convenience = Compliance · ADVANCED PNEUMATIC COMPRESSION SYSTEM. ... (JAMA) Dermatology Ñ Study Highlights A study of 718 lymphedema patients

The Flexitouch® Plus is the only pneumatic compression device that has been clinically

proven to stimulate the lymphatic system.1 With our third-generation garments

and controller, the Flexitouch Plus makes it even easier for patients to benefit from

this advanced at-home therapy.

ADVANCED TECHNOLOGY THAT’S EASY TO USE.

G A R M E N T F E AT U R E S

S I M U LTA N E O U S B I L AT E R A L T H E R A P Y saves patients treatment time

I N T U I T I V E D E S I G N allows lower extremity garments to slide on like boots; trunk garments slide on like shorts

E N H A N C E D C LO S U R E S make garments easier to put on and take off, while maintaining the ability to fit each patient’s individual body shape

U N I Q U E C H A M B E R D E S I G N supports gentle and dynamic mechanism of action

R E M O VA B L E H O O K A N D LO O P PA D S increase garment lifespan

O N E - H A N D H O S E AT TAC H M E N T connects with push-and-click motion

Page 3: Improve Patient Outcomes Comfort + Convenience = Compliance · ADVANCED PNEUMATIC COMPRESSION SYSTEM. ... (JAMA) Dermatology Ñ Study Highlights A study of 718 lymphedema patients

CO N T R O L L E R F E AT U R E S

L A R G E 7” CO LO R D I S P L AY with easy-to-read instructions

L A R G E B U T TO N S for easy operation

CO U N T D O W N T I M E R shows time remaining

S TO R E S U P TO T H R E E P R E S E T P R O G R A M S for added convenience

CO M PAC T F O OT P R I N T for easy storage

P O R TA B L E D E V I C E W I T H I N T E G R AT E D H A N D L E D E S I G N for travel-ready, compact portability

96% Patient Satisfaction2

“ I LO V E T H I S M AC H I N E . I A M A B L E TO W E A R B O OT S A N D A N A N K L E B R AC E L E T.

L I T T L E ACCO M P L I S H M E N T S TO S O M E , B U T E X T R E M E LY E XC I T I N G TO M E !”

— B E L I N D A , F L E X I TO U C H P LU S U S E R

Page 4: Improve Patient Outcomes Comfort + Convenience = Compliance · ADVANCED PNEUMATIC COMPRESSION SYSTEM. ... (JAMA) Dermatology Ñ Study Highlights A study of 718 lymphedema patients

The Flexitouch Plus system uses a unique mechanism of action that has been

clinically proven to improve outcomes, reduce costs and improve the quality of life

for patients.2,4

T H E C L I N I C A L LY P R O V E N R E S U LT S YO U H AV E CO M E TO E X P E C T F R O M T H E F L E X I TO U C H S YS T E M

*For Cancer-Related Patients **For Non-Cancer-Related Patients †Excluding Medical Equipment

F L E X I TO U C H S YS T E M C L I N I C A L E V I D E N C EJournal of the American Medical Association (JAMA) Dermatology — Study Highlights

A study of 718 lymphedema patients evaluating patient health outcomes and healthcare costs in cancer and non-cancer cohorts.4

79% Reduction in

Rate of Cellulitis Episodes*

75% Reduction Among Non-Cancer Patients

54% Reduction in

Rate of Inpatient Hospitalizations**

22% Reduction Among Cancer Patients

40% Reduction in

Rate of Outpatient Hospital Visits**

29% Reduction Among Cancer Patients

34% Reduction in

Rate of Physical Therapy Visits**

30% Reduction Among Cancer Patients

37% Reduction in

Total Lymphedema-Related Costs†

Per Patient*

36% Reduction Among Non-Cancer Patients

79% 54% 40% 34% 37%

CO S T S O F H O S P I TA L I Z AT I O N F R O M C E L LU L I T I S M AY E XC E E D $16,000 P E R Y E A R.5

AV O I D I N G A S I N G L E H O S P I TA L I Z AT I O N D U E TO C E L LU L I T I S

CO U L D S AV E PAT I E N T S M O R E T H A N 4 D AYS I N T H E H O S P I TA L .6

Page 5: Improve Patient Outcomes Comfort + Convenience = Compliance · ADVANCED PNEUMATIC COMPRESSION SYSTEM. ... (JAMA) Dermatology Ñ Study Highlights A study of 718 lymphedema patients

95% Maintained or

Reduced Limb Volume

90%Reported Satisfaction

with Flexitouch At-Home Treatment

96%Were Compliant with the

Prescribed Therapy

93% Among Non-Cancer-Related Lymphedema Patients

I M P R O V E D O U TCO M E S . H I G H S AT I S FAC T I O N . I N C R E A S E D CO M P L I A N C E .

In a clinical study following 155 lymphedema patients, Flexitouch use resulted in improved outcomes, high satisfaction and high compliance:2

“ T H E F I R S T T I M E I U S E D T H E F L E X I TO U C H AT H O M E I C R I E D B E C AU S E I T B R O U G H T M Y

A R M S U C H CO M F O R T. N OT H I N G I T R I E D B E F O R E E V E R G AV E M E S U C H R E L I E F.”

— J U D I T H , F L E X I TO U C H U S E R

Page 6: Improve Patient Outcomes Comfort + Convenience = Compliance · ADVANCED PNEUMATIC COMPRESSION SYSTEM. ... (JAMA) Dermatology Ñ Study Highlights A study of 718 lymphedema patients

Near infrared imaging demonstrates lymph movement toward axillary nodes following

Flexitouch therapy1 in a breast cancer-related lymphedema patient:

T H E O N LY P N E U M AT I C CO M P R E S S I O ND E V I C E P R O V E N TO S T I M U L AT ET H E LY M P H AT I C S YS T E M

P R E - F L E X I TO U C H P O S T - F L E X I TO U C H

Evidence of increased lymphatic activity and movement toward axilla

“ I D I D N OT T H I N K A N Y K I N D O F T H E R A P Y W O U L D W O R K , B U T N O W I C A N S L E E P

O N M Y B AC K . I C A N M O V E A R O U N D M O R E E A S I LY, A N D I F E E L B E T T E R .”

— FAY E , F L E X I TO U C H U S E R

Clinical evidence shows the Flexitouch system significantly improves clinical outcomes:3

88% Experienced Limb Volume

Reduction (35% Experienced Reduction of >10%)

86%Experienced a

Reduction in Fibrosis

85%Demonstrated

Increased Ability to Perform Activities of Daily Living

Page 7: Improve Patient Outcomes Comfort + Convenience = Compliance · ADVANCED PNEUMATIC COMPRESSION SYSTEM. ... (JAMA) Dermatology Ñ Study Highlights A study of 718 lymphedema patients

H O W I T W O R K S

THE FIRST AND ONLY PNEUMATIC COMPRESSION THER APY SPECIFIC ALLY DESIGNED TO TREAT HEAD AND NECK LYMPHEDEMA

The head and neck garment set is easy to use and features the clinically proven Flexitouch technology that tens of thousands of lymphedema patients currently rely on every day to effectively treat their extremities.

“ I T W O R K S G R E AT !

M Y N E C K LO O K S N O R M A L .”

— D O N , F L E X I TO U C H U S E R

Our unique garment chambers stimulate the lymphatic system to remove excess fluid and reduce edema. The pneumatic chambers sequentially inflate and deflate for just a few seconds each, creating a gentle wave-like application of pressure to stimulate the movement of lymphatic fluid and direct it toward properly functioning areas of the body.

“ I LO V E M Y F L E X I TO U C H .

I T I S V E R Y E A S Y TO U S E A N D I T I S L I K E A M A S S AG E .”

— M A R Y S . , F L E X I TO U C H U S E R

Page 8: Improve Patient Outcomes Comfort + Convenience = Compliance · ADVANCED PNEUMATIC COMPRESSION SYSTEM. ... (JAMA) Dermatology Ñ Study Highlights A study of 718 lymphedema patients

Individual results may vary.

Indications/contraindications: Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.

Caution: Federal (USA) law restricts these devices to sale by or on the order of a licensed healthcare practitioner.

References:1. Adams KE, Rasmussen JC, Darne C, Tan I, Aldrich MB, Marshall MV, Fife CE, Maus EA, Smith LA, Guilliod R, Hoy S, Sevic-Muraca EM. Direct evidence of lymphatic function

improvement after advanced pneumatic compression device treatment of lymphedema. Biomedical Optics Express. August 2010 (Vol 1/No 1).2. Ridner SH, McMahon E, et al. Home-based lymphedema treatment in patients with and without cancer-related lymphedema. Oncol Nurs Forum. 2008; 35(4): 671–680.3. Muluk SC, Hirsch AT, Tafe EC. Pneumatic compression device treatment of lower extremity lymphedema elicits improved limb volume and patient-reported outcomes. Eur J Vasc

Endovasc Surg. 2013; 46(4): 480–487.4. Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH. The cutaneous, net clinical, and health economic benefits of advanced pneumatic compression devices in patients with

lymphedema. JAMA Dermatol. 2015; 151(11): 1187–1193. The study analyzed upper and lower extremity lymphedema patients with cancer related (4a) and non-cancer related lymphedema (4b) treated with the Flexitouch System. The reduction rate of inpatient hospitalization was not statistically significant (4c). Total costs excluded medical equipment (4d). The study evaluated use of the Flexitouch System as a tool for the treatment of lymphedema. The study documented a reduction in the rate of cellulitis episodes following use of the Flexitouch System for the treatment of lymphedema. The Flexitouch System is not used for nor intended for use to treat cellulitis.

5. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/nchs/data/nhds/2average/2010ave2_firstlist.pdf. Accessed May, 2015. 6. The Official Website of New York State. Available at: https://health.data.ny.gov/Health/Cellulitis-Other-Bacterial-Skin-Infections-Hospita/3med-x5jj. Accessed May, 2015.

Tactile Medical 1331 Tyler Street NE, Suite 200Minneapolis, MN 55413 USAT: 612.355.5100 F: 612.355.5101

Customer ServiceToll-Free Tel: 866.435.3948Toll-Free Fax: 866.435.3949Hours: Monday through Friday, 7 a.m. – 7 p.m. CTwww.tactilemedical.com

Flexitouch is a registered trademark, and Healing Right at Home is a trademark of Tactile Medical. ©2017 Tactile Medical. All rights reserved. D/N: 500280-300-00 Rev. A 12/2017

SEE HOW WE’RE BRINGING THE FUTURE OF HEALING HOME AT TAC TILEMEDIC AL.COM

Tactile Medical is a leader in developing and marketing at-home therapy devices that treat

lymphedema and chronic venous insufficiency. Our mission is to help people suffering from chronic

diseases live better and care for themselves at home. Our unique offering includes advanced, clinically

proven pneumatic compression devices, as well as continuity of care services provided by a national

network of product specialists and trainers, reimbursement experts, patient advocates and clinicians.

This combination of products and services ensures that tens of thousands of patients annually receive

the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes

pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and

improve the quality of life for patients with chronic conditions.